"/> Invitrogen™ Peptide synthétique DcR3 humain | B-LABO France

Invitrogen™ Peptide synthétique DcR3 humain

Réf. : BL-RE-175495Réf. fabricant : 15226279 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
8771
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
O95407
Nom usuel
Human DcR3
Marque
Invitrogen

DcR3 Synthetic Peptide, PEP-0049, from Invitrogen.

Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF (tumor necrosis factor) and Fas ligand of the TNF family through their death domain containing receptors, TNFR1 (tumor necrosis factor receptor 1) and Fas. Cell death signals are transduced by death domain (DD)-containing adapter molecules and members of the ICE (interleukin-1-beta converting enzyme)/CED-3 (C. elegans death receptor-3) protease family. A novel DD-containing molecule was recently cloned from mouse, human and monkey and designated Daxx (death associated protein 6). Daxx binds specifically to the Fas death domain and enhances Fas induced apoptosis and activates the Jun N-terminal kinase (JNK) pathway. Daxx is widely expressed in fetal and adult human and mouse tissues indicating its important function in Fas signaling pathways.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175495
Réf. fabricant15226279
Gene ID (Entrez)8771
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionO95407
Nom usuelHuman DcR3
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)TNFRSF6B
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.